These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 18007155

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S, Ebert W, Schultze-Mosgau M, Breuer J.
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [Abstract] [Full Text] [Related]

  • 3. Toxicological safety evaluation of gadobutrol.
    Wack C, Steger-Hartmann T, Mylecraine L, Hofmeister R.
    Invest Radiol; 2012 Nov; 47(11):611-23. PubMed ID: 23011188
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S, Inoue Y, Watanabe M, Izawa K, Shimada M, Tojo A, Yoshikawa K, Ohtomo K.
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [Abstract] [Full Text] [Related]

  • 5. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
    Tsuda N, Okada M, Murakami T.
    Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings.
    Kitajima K, Yoshikawa T, Seo Y, Ohno Y, Yano Y, Miki A, Kanda T, Kanata N, Azuma T, Sugimura K.
    Magn Reson Imaging; 2011 May; 29(4):579-83. PubMed ID: 21216550
    [Abstract] [Full Text] [Related]

  • 13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials.
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [Abstract] [Full Text] [Related]

  • 14. Nonlinear pharmacokinetic modeling of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G.
    Arzneimittelforschung; 1993 Sep; 43(9):1020-4. PubMed ID: 8240452
    [Abstract] [Full Text] [Related]

  • 15. Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors.
    Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T.
    Invest Radiol; 2004 Feb; 39(2):80-8. PubMed ID: 14734922
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preclinical testing of iopromide. 2nd communication: toxicological evaluation.
    Krause W, Schöbel C, Press WR.
    Arzneimittelforschung; 1994 Nov; 44(11):1275-9. PubMed ID: 7848345
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.